Total Number of Pages: 5
Exhibit Index on Sequential Page No.: 3
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 1995
ORNDA HEALTHCORP
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
0-11290 75-1776092
(Commission File Number) (IRS Employer Identification No.)
3401 West End Avenue, Nashville, Tennessee 37203
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: (615) 383-8599<PAGE>
Item 5. Other Events.
The Registrant hereby incorporates by reference the description of
the matter set forth in its news release dated November 6, 1995 (such news
release being Exhibit 99 attached hereto).
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99 Registrant's news release dated November 6, 1995.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ORNDA HEALTHCORP
(Signature)
Ronald P. Soltman
Senior Vice President
Date: November 8, 1995<PAGE>
EXHIBIT INDEX
Sequential
No. Subject Matter Page No.
99 Registrant's new release dated November 6, 1995.. . . . . . . . .4<PAGE>
Exhibit 99<PAGE>
FOR IMMEDIATE RELEASE
Contact: Keith B. Pitts
Executive Vice President and Chief Financial Officer
or
Tripp Pilgrim
Director of Investor Relations
OrNda HealthCorp
(615) 383-8599
ORNDA COMPLETES THE PUBLIC OFFERING OF ITS COMMON STOCK
NASHVILLE, Tennessee (November 6, 1995) - OrNda HealthCorp (Nasdaq
NM: ORND) announced completion of a public offering of 10 million shares of
its Common Stock at a $17.625 per share public offering price. All of the
shares were sold by OrNda.
Merrill Lynch & Co. and its international affiliate were the lead
managers of both the offering in the United States and Canada of 8 million
shares and the concurrent international offering of 2 million shares, with
Donaldson, Lufkin & Jenrette Securities Corporation, Smith Barney Inc. and
Johnson Rice & Company L.L.C. acting as co-managers for both offerings.
OrNda has granted the underwriters an option for 30 days to purchase up to an
additional 1.5 million shares solely to cover over-allotments.
OrNda received approximately $168 million in aggregate net
proceeds from these offerings. OrNda intends to use the net proceeds from
these offerings (as well as the proceeds from any exercise of the
over-allotment option) to reduce existing bank indebtedness and for
general corporate purposes, including strategic acquisitions.
OrNda HealthCorp is the third largest investor-owned hospital
management company in the United States. It is a leading provider of health
care services, delivering a broad range of inpatient and outpatient health
care services principally through the operation of 47 hospitals located in
urban and suburban communities in 14 states.
# # #
